Oct 1, 2011
By:
William Looney
Napoleone Ferrara, MD, PhD, Research Fellow, Genentech
|
Oct 1, 2011
By:
William Looney
Dennis Gillings, Chairman & CEO, Quintils Transnational Corp.
|
Oct 1, 2011
By:
William Looney
P. Roy Vagelos, MD, Chairman Emeritus, Merck
|
Oct 1, 2011
By:
William Looney
Candan Karabagli, CEO, Abdi Ibrahim A.S.
|
Oct 1, 2011
By:
William Looney
Antonio Gotto, MD, Dean, Weill Cornell Medical College
|
Sep 1, 2011
By:
William Looney
Pharm Exec talks to Dr. Mel Spigelman, President and CEO of the TB Alliance, about the organization's tuberculosis priorities.
|
|
Sep 1, 2011
By:
William Looney
Can cooperative ties between Big Pharma, NGOs, government, and international organizations pay the freight in making the fight against neglected diseases a permanent fix in global health?
|
Sep 1, 2011
By:
William Looney
Despite the gloom, most forecasts show the US will stay atop the industry in profits for at least the next generation of products.
|
Aug 1, 2011
By:
William Looney, Ben Comer
No one doubts the importance of health expenditures ? but then, euros, like dollars, don't grow on trees
|
|
PharmExec Blog
Follow Us
RSS
Bookstore
